Solara Active Pharma Sciences informs about press release

19 Nov 2025 Evaluate

Solara Active Pharma Sciences has informed that it enclosed a press release issued by the Company titled hereunder, with respect to the EIR (Establishment Inspection Report) received from US FDA for the inspection completed and classified as VAI (Voluntary Action Indicated). ‘Solara is pleased to announce the successful closure of US FDA inspection of its Mangalore Facility with continued state of compliance on cGMP’.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

552.00 1.65 (0.30%)
05-Dec-2025 13:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.80
Dr. Reddys Lab 1277.40
Cipla 1526.95
Zydus Lifesciences 934.00
Lupin 2102.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×